Clinical application of perfusion and diffusion MR imaging in acute ischemic stroke

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 3, 1999, Pages 305-309

  Ueda, Toshihiro ^a   Yuh, William T C ^a   Taoka, Toshiaki ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Acute ischemic stroke; Diffusion MR imaging; Penumbra; Perfusion MR imaging; Reversibility; Viability

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PROUROKINASE;

ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN HEMORRHAGE; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; COLLATERAL CIRCULATION; DIFFUSION; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; REPERFUSION INJURY; TREATMENT PLANNING;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; THROMBOLYTIC THERAPY;

EID: 0032863413     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199909)10:3<305::AID-JMRI11>3.0.CO;2-1     Document Type: Article

References (51)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998:29:4-11.
3. Furlan AJ, Higashida R, Wechsler L, Schlz G, PROACT II Investigators. PROACT II: prourokinase (r-ProUK) in acute cerebral thromboembolism: initial trial results. Stroke 1999;30:234.
4. Ueda T, Sakaki S, Nochide I, et al. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998;29:2568-2574.
5. Fisher M. Characterizing the target of acute stroke therapy. Stroke 1997;28:866-872.
6. Yuh WTC, Maeda M, Wang AM, et al. Fibrinolytic treatment of acute stroke: are we treating reversible cerebral ischemia? AJNR Am J Neuroradlol 1995;16:1994-2000.
7. Ueda T, HatakeyamaT, Kumon Y, Sakaki S, Uraoka T. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by Initial SPECT. Stroke 1994;25:298-303.
8. Ueda T, Sakaki S, Yuh WTC, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 1999;19:99-108.
9. Ueda T, Yuh WTC, Maley JE, et al. Evaluation of reversibility of acute ischemic lesions detected by perfusion MR imaging. In: Proceedings of the 37th Annual Meeting of American Society of Neuroradiology. San Diego, CA, May, 1999.
10. Kobayashi M, Lust WD, Passonneau JV. Concentrations of energy metabolites and cyclic nucleotides during and after bilateral ischemia in the gerbil cerebral cortex. J Neurochem 1977;29:53-59.
11. Bell BA, Symon L, Branston NM. CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons. J Neurosurg 1985;62:31-41.
12. Moseley M, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion-and T2-weighted MRI and spectroscopy. Magn Reson Med 1990;14:330-346.
13. Symon L, Branston N, Strong A, Hope T. The concept of thresholds of ischaemia in relation to brain structure and function. J Clin Pathol 1977;30(suppl 11):149-154
14. Astrup J, Symon L, Siesjö B. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 1981;12:723-725.
15. Hossmann K-A. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557-565.
16. Fisher M, Carcia J. Evolving stroke and the ischemic penumbra. Neurology 1996;47:884-888.
17. Ginsberg MD. The new language of cerebral ischemia. AJNR Am J Neuroradiol 1997;18:1435-1445.
18. Marchal G, Beaudouin V, Rioux P, et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke 1996;27.
19. Furlan M, Viader F, Derlon J, Baron J. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996;40:216-226.
20. Heiss H-D, Huber M, et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992;12:193-203
21. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998;18:583-609.
22. Busza AL, Allen KL, King MD, et al. Diffusion-weighted imaging studies of cerebral ischemia in gerbils. Potential relevance to energy failure. Stroke 1992;23:1602-1612.
23. Kohno K, Hoehn-Berlage M, Mies G, Back T, Hossmann K-A. Relationship between diffusion-weighted MR images, cerebral blood flow, and energy state in experimental brain infarction. Magn Reson Imaging 1995;13:73-80.
24. Lövblad KO, Laubach HJ, Baird AE, et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol 1998;19:1061-1066.
25. Gonzalez RG, Schaefer PW, Buonanno FS, et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999;210:155-162.
26. Lövblad K, Baird A, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164-170.
27. van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LMP, Mali WPTM. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 1998;29:1783-1790.
28. Schlaug G, Siewert B, Benfield A, Edelman R, Warach S. Time course of the apparent diffusion coeffient (ADC) abnormality in human stroke. Neurology 1997;49:113-119.
29. Bryan R. Diffusion-weighted imaging: to treat or not to treat? that is the question. AJNR Am J Neuroradiol 1998;19:396-397.
30. Powers WJ, Zivin J. Magnetic resonance imaging in acute stroke: not ready for prime time. Neurology 1998;50:842-843.
31. Davis D, Ulatowski J, Eleff S, et al. Rapid monitoring of changes in water diffusion coefficients during reversible ischemia in cat and rat brain. Magn Reson Med 1994;31:454-460.
32. Miyabe M, Mori S. van Zijl PCM, et al. Correlation of the average water diffusion constant with cerebral blood flow and ischemic damage after transient middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1996;16:881-889.
33. Ueda T, Yuh WTC, Joan ME, et al. Outcome of acute ischemic lesions detected by diffusion and perfusion MR imaging. AJNR Am J Neuroradiol 1999;20:983-990.
34. Maeda M, Maley J, Crosby D, et al. Application of contrast agents in the evaluation of stroke: conventional MR and echo-planar MR imaging. J Magn Reson Imaging 1997;7:23-28.
35. Maeda M, Yuh WTC, Ueda T, et al. Severe occlusive carotid artery disease: Hemodynamic assessment by MR perfusion imaging in symptomatic patients. AJNR Am J Neuroradiol 1999;20:43-51.
36. Finelli DA, Hopkins AL, Selman WR, et al. Evaluation of experimental early acute cerebral ischemia before the development of edema: use of dynamic, contrast-enhanced and diffusion-weighted MR scanning. Magn Reson Med 1992;27:189-197.
37. Hamberg LM, Macfarlane R, Tasdemiroglu E, et al. Mesurement of cerebravascular changes in cats after transient ischemia using dynamic megnetic resonance imaging. Stroke 1993;24:444-451.
38. Kucharczyk J, Mintorovitch J, Asgari HS. Diffusion/perfusion MR imaging of acute cerebral ischemia. Magn Reson Med 1991;19:311-315.
39. Wendland MF, White DL, Aicher KP, Tzika AA, Moseley ME. Detection with echo-planar MR imaging of transit of susceptibility contrast medium in a rat model of regional brain ischemia. J Magn Reson Imaging 1991;1:285-292.
40. Jiang Q, Zhang RL, Zhang ZG, et al. Diffusion-, T2-, and perfusion-weighted nucler magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. J Cereb Blood Flow Metab 1998;18:758-767.
41. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299.
42. Gückel F, Brix G, Rempp K, et al. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient-echo imaging. J Comput Assist Tomogr 1994;18:344-351.
43. Tong DC, Yenari MA, Albers GW, et al. Correlation of perfusion-and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 1998;50:864-870.
44. Sorensen A, Buonanno E, Gonzalez R, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996;199:391-401.
45. Rordorf G, Koroshetz WJ, Copen WA, et al. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998;29:939-943.
46. Röther J, Gückel F, Neff W. Assessment of regional cerebral blood volume in acute human stroke by use of single-slice dynamic susceptibility contrast-enhanced magnetic resonance imaging. Stroke 1996;27:1088-1093.
47. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion-and diffusion-weigh ted MRI. Neurology 1998;51:418-426.
48. Sorenson AG, Copen WA, Ostergaard L, et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999;210:519-527.
49. Jahan R, Kidwell SC, Alger JR, Saver JL, Mattillo J, Starkman S, Duckwiler G, Gobin YP, Vinuela F, Kalafut M, Vespa P. Reversibility of abnormal diffusion MR imaging postthrombolysis for acute ischemic stroke. In: Proceedings of the 37th annual meeting of the American Society of Neuroradiology, San Diego, CA, 1999.
50. Kidwell SC, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, Saver JL. Diffusion MRI patients with transient ischemic attacks stroke. 1999;30:1174-1180.
51. Latchaw RE. The roles of diffusion and perfusion imaging in acute stroke management. AJNR Am J Neuroradiol 1999;20:957-958.